FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3059133087> ?p ?o ?g. }

• W3059133087 endingPage "903" @default.
• W3059133087 startingPage "897" @default.
• W3059133087 abstract "ObjectivesTo analyse functional outcome parameters according to antimicrobial treatments after respiratory syncytial virus (RSV)-confirmed infection in adult lung transplant recipients.MethodsA 9-year retrospective multicentre cohort study (2011–19) included adult lung transplant recipients with RSV-confirmed infection. The first endpoint determined new allograft dysfunction (acute graft rejection and chronic lung allograft dysfunction (CLAD)) 3 months after infection. Then baseline and 3 months' postinfection forced expiratory volume in 1 second (FEV1) values were compared according to antimicrobial treatment. Univariate logistic regression analysis was performed.ResultsRSV infection was confirmed in 77 of 424 lung transplant recipients (estimated incidence of 0.025 per patient per year; 95% confidence interval 0.018–0.036). At 3 months, 22 recipients (28.8%) developed allograft dysfunction: ten (13%) possible CLAD, six (7.9%) acute rejection and six (7.9%) CLAD. Recipients with the lowest preinfection FEV1 had a greater risk of developing pneumonia (median (interquartile range) 1.5 (1.1–1.9) vs. 2.2 (1.5–2.4) L/s, p 0.003) and a higher odds of receiving antibiotics (1.6 (1.3–2.3) vs. 2.3 (1.9–2.5) L/s, p 0.017; odds ratio 0.52, 95% confidence interval 0.27–0.99). Compared to tracheobronchitis/bronchiolitis, RSV-induced pneumonia led more frequently to hospitalization (91.7%, 22 vs. 58.0%, 29, p 0.003) and intensive care unit admission (33.3%, 8 vs. 0, p < 10-3). For ribavirin-treated recipients (24.7%, 19) and azithromycin prophylaxis (50.6%, 39), 3-month FEV1 values were not different from untreated recipients. The overall mortality was 2.5% at 1 month and 5.3% at 6 months, unrelated to RSV.ConclusionsAt 3 months after RSV-confirmed infection, 22 recipients (28.8%) had new allograft dysfunction. Ribavirin treatment and azithromycin prophylaxis did not prevent FEV1 decline." @default.
• W3059133087 created "2020-08-24" @default.
• W3059133087 creator A5001508020 @default.
• W3059133087 creator A5002459038 @default.
• W3059133087 creator A5013122234 @default.
• W3059133087 creator A5020437282 @default.
• W3059133087 creator A5030727982 @default.
• W3059133087 creator A5055852106 @default.
• W3059133087 creator A5060944412 @default.
• W3059133087 creator A5063396107 @default.
• W3059133087 creator A5064668101 @default.
• W3059133087 creator A5085315721 @default.
• W3059133087 creator A5088119429 @default.
• W3059133087 date "2021-06-01" @default.
• W3059133087 modified "2023-10-18" @default.
• W3059133087 title "Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study" @default.
• W3059133087 cites W1982645079 @default.
• W3059133087 cites W1999132685 @default.
• W3059133087 cites W2004397336 @default.
• W3059133087 cites W2016263114 @default.
• W3059133087 cites W2030603863 @default.
• W3059133087 cites W2036525032 @default.
• W3059133087 cites W2039688361 @default.
• W3059133087 cites W2045656371 @default.
• W3059133087 cites W2065755766 @default.
• W3059133087 cites W2083208010 @default.
• W3059133087 cites W2085068503 @default.
• W3059133087 cites W2115027948 @default.
• W3059133087 cites W2120725049 @default.
• W3059133087 cites W2127410396 @default.
• W3059133087 cites W2139556962 @default.
• W3059133087 cites W2144777080 @default.
• W3059133087 cites W2146407494 @default.
• W3059133087 cites W2161348191 @default.
• W3059133087 cites W2166870547 @default.
• W3059133087 cites W2173954271 @default.
• W3059133087 cites W2316631733 @default.
• W3059133087 cites W2496045348 @default.
• W3059133087 cites W2519089586 @default.
• W3059133087 cites W2558274900 @default.
• W3059133087 cites W2737585766 @default.
• W3059133087 cites W2897348739 @default.
• W3059133087 cites W2918940752 @default.
• W3059133087 cites W2933321059 @default.
• W3059133087 doi "https://doi.org/10.1016/j.cmi.2020.07.050" @default.
• W3059133087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32827713" @default.
• W3059133087 hasPublicationYear "2021" @default.
• W3059133087 type Work @default.
• W3059133087 sameAs 3059133087 @default.
• W3059133087 citedByCount "6" @default.
• W3059133087 countsByYear W30591330872021 @default.
• W3059133087 countsByYear W30591330872022 @default.
• W3059133087 countsByYear W30591330872023 @default.
• W3059133087 crossrefType "journal-article" @default.
• W3059133087 hasAuthorship W3059133087A5001508020 @default.
• W3059133087 hasAuthorship W3059133087A5002459038 @default.
• W3059133087 hasAuthorship W3059133087A5013122234 @default.
• W3059133087 hasAuthorship W3059133087A5020437282 @default.
• W3059133087 hasAuthorship W3059133087A5030727982 @default.
• W3059133087 hasAuthorship W3059133087A5055852106 @default.
• W3059133087 hasAuthorship W3059133087A5060944412 @default.
• W3059133087 hasAuthorship W3059133087A5063396107 @default.
• W3059133087 hasAuthorship W3059133087A5064668101 @default.
• W3059133087 hasAuthorship W3059133087A5085315721 @default.
• W3059133087 hasAuthorship W3059133087A5088119429 @default.
• W3059133087 hasBestOaLocation W30591330871 @default.
• W3059133087 hasConcept C119060515 @default.
• W3059133087 hasConcept C120665830 @default.
• W3059133087 hasConcept C121332964 @default.
• W3059133087 hasConcept C126322002 @default.
• W3059133087 hasConcept C141071460 @default.
• W3059133087 hasConcept C144301174 @default.
• W3059133087 hasConcept C156957248 @default.
• W3059133087 hasConcept C167135981 @default.
• W3059133087 hasConcept C203014093 @default.
• W3059133087 hasConcept C2522874641 @default.
• W3059133087 hasConcept C2776408679 @default.
• W3059133087 hasConcept C2777914695 @default.
• W3059133087 hasConcept C2778821649 @default.
• W3059133087 hasConcept C2780040827 @default.
• W3059133087 hasConcept C2781448352 @default.
• W3059133087 hasConcept C2911091166 @default.
• W3059133087 hasConcept C38180746 @default.
• W3059133087 hasConcept C44249647 @default.
• W3059133087 hasConcept C534529494 @default.
• W3059133087 hasConcept C61511704 @default.
• W3059133087 hasConcept C71924100 @default.
• W3059133087 hasConcept C90924648 @default.
• W3059133087 hasConceptScore W3059133087C119060515 @default.
• W3059133087 hasConceptScore W3059133087C120665830 @default.
• W3059133087 hasConceptScore W3059133087C121332964 @default.
• W3059133087 hasConceptScore W3059133087C126322002 @default.
• W3059133087 hasConceptScore W3059133087C141071460 @default.
• W3059133087 hasConceptScore W3059133087C144301174 @default.
• W3059133087 hasConceptScore W3059133087C156957248 @default.
• W3059133087 hasConceptScore W3059133087C167135981 @default.
• W3059133087 hasConceptScore W3059133087C203014093 @default.
• W3059133087 hasConceptScore W3059133087C2522874641 @default.

• next